Residential REIT's

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend that ADASUVE™ (Staccato® loxapine) be approved for use as a single dose in 24 hours when used with the FDA recommended...

MAA (NYSE: MAA) announced today that it has completed the acquisitions of Palisades at Chenal Valley, a 248-unit apartment community located in Little Rock, Arkansas and The River's Walk at Celebrate Virginia, a 232-unit apartment community located in Fredericksburg, Virginia.

MAA (NYSE: MAA) announced today that Thomas L. Grimes, Jr. has been appointed Executive Vice-President and Chief Operating Officer.  Mr. Grimes joined the company in 1994 shortly after MAA's initial public offering and has served as Executive Vice-President and Director of Property Management...

MAA (NYSE: MAA) today announced that its board of directors voted to increase the quarterly common dividend by 5.2% to a quarterly payment of $0.66 per share, or $2.64 per share on an annual basis. 

Dynavax Technologies Corporation (NASDAQ: DVAX) today said that the U.S. Food and Drug Administration had concurred with the company's plan to submit a Biologics License Application for HEPLISAV for persons over 40 years of age, followed by a supplemental BLA for licensure of a specific regimen for...

MAA (NYSE: MAA) announced today that it has completed the acquisition of Aventura at Indian Lake Village, a 300-unit apartment community located in the Nashville metropolitan statistical area.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for KALYDECO™ (VX-770, ivacaftor), a medicine in development that targets the defective protein that causes cystic fibrosis. KALYDECO (kuh...

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer International, S.A., announced today that they entered into a commercial partnership for Adasuve™ (Staccato® loxapine). ADASUVE is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Grupo Ferrer...

MAA (NYSE: MAA) today announced that its Board of Directors approved a quarterly common dividend of $0.6275 per share payable on October 31, 2011 to shareholders of record on October 14, 2011.

According to J.P. Morgan, UDR (NYSE: UDR) price target is raised to $27. J.P. Morgan said that it is updating its model and estimates post 2Q earnings. “We are raising our 2011 and AFFO estimate by a penny to $1.03 and maintaining our 2012 AFFO estimate of $1.16/share. Our estimates incorporate $1...

JP Morgan has raised the price target on UDR (NYSE: UDR) from $26 to $27 and maintains its Overweight rating.

MAA (NYSE: MAA) announced today that it has completed the acquisition of Birchall at Ross Bridge, a 240-unit upscale apartment community located in the highly desirable South sub-market of Hoover, Alabama in the Birmingham metropolitan statistical area. Birchall at Ross Bridge is a condo-quality...

How far will industry groups go to protect their interests? A recent exposé by California Watch shows that some will take their PR campaigns to the schools. California school officials edited an environmental curriculum after being pressured by the American Chemistry Council (ACC) to endorse...

According to Ladenburg Thalmann, Sun Communities (NYSE: SUI) coverage is initiated with a Buy rating. Ladenburg Thalmann said that it is initiating coverage on SUI with a Buy rating and $43 price target. “We like the turnaround nature of the SUI story.” Sun Communities closed yesterday at $35.66...

Ladenburg Thalmann has initiated coverage on Sun Communities (NYSE: SUI) with a Buy rating and $43 price target.